The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...
The European Medicines Agency (EMA) says its safety committee has begun a review into reports of an association between use of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and a ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 33 tables and 60 figures, this 119-page report Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by ...
While the FDA, European Medicines Agency (EMA), and the UK’s Medicines ... as specified in the recent EU pharmacovigilance legislation. Examining the findings of the MHRA’s most recent ...
Heads of R&D at all major pharma companies have come together to express their concerns about severe disruption to the European Medicines Agency ... in approvals and pharmacovigilance for two ...
Zoetis Inc. today announced that it has updated the U.S. label for Librela® (bedinvetmab injection), following its submission ...
A new method has been created for determining N-nitrosamines (NAs) in pharmaceutical preparations using liquid chromatography with tandem mass spectrometry.
Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...
The label update is a response to real-world drug experience data reported to the FDA and collected through Zoetis' pharmacovigilance ... defined by the European Medicines Agency.
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
In 2024, toripalimab received approvals from both the European Commission (EC) and the UK Medicines and Healthcare Products Regulatory Agency (MHRA ... registration, pharmacovigilance, quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results